Receptor-Based Prediction of Binding Affinities

Perspectives in Drug Discovery and Design

Volumn 9--11, Issue , 1998, Pages 35-61

  Oprea, Tudor I ^a   Marshall, Garland R ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542529333     PISSN: 09282866     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Gund, P., Three-dimensional pharmacophoric pattern searching, Prog. Mol. Subcell. Biol., 11 (1997). 117-143.
2. Jakes, S.E., Watts, N., Willett, P., Bawden, D., and Fisher, J.D., Pharmacophoric pattern matching in files of 3D chemical structures: Evaluation of search performance, J. Mol. Graph., 5. (1987), 41-48.
3. Jakes, S.E., and Willett, P., Pharmacophoric pattern matching in files of 3D chemical structures: Selection of interatomic distance screens, J. Mol. Graphics, 4, (1986) 12-20.
4. Sheridan, R.P., Rusinko, A., III, Nilakantan, R., Venkataraghavan R., Searching for pharmacophores in large coordinate data bases and its use in drug design, Proc. Natl. Acad. Sci. USA, 86, (1989), 8165-8169.
5. Van Drie, J.H., Weininger, D., and Martin, Y.C., ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric and substructure searching of three-dimensional molecular structures, J. Comput.-Aided Mol. Design, 3 (1989) 225-251.
6. Martin, Y.C., 3D Database Searching in Drug Design, J. Med. Chem. , 35 (1992), 2145-2154.
7. Martin, Y.C., Bures, M.G., Danaher, E.A., and DeLazzer, J., New strategies that improve the efficiency of the 3D design of bioctive molecules, In Trends in QSAR and molecular modelling 92, Wermuth, C.G., (Ed.) ESCOM, Leiden, 1993, P. 20-27.
8. Kuntz, I.D, Blaney, J.M., Oatley, S.J., Langridge, R. and Ferrin, T.E., A geometric approach to macromolecule-ligand interactions, J. Mol. Biol., 161 (1982) 269-288.
9. DesJarlais, R.L., Seibel, G.L., Dixon, J.S., and Kuntz, I.D., Using shape complimentarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure, J. Med. Chem., 31 (1990) 722-729.
10. DesJarlais, R.L., Seibel, G.L., Kuntz, I.D., Furth, P.S., Alvarez, J.C., de Montellano, P.R O., DeCamp, D.L., Babe, L.M. Craik, C.S., Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease, Proc. Natl. Acad. Sci. USA, 87, (1990) 6644-6648.
11. Oshiro, C.M., Kuntz, I.D., Dixon, J.S., Flexible ligand docking using a genetic algorithm, J. Comput.-Aided Mol. Design, 9 (1995) 113-130.
12. Ring C, Sun E., McKerrow J., Lee G., Rosenthal P., Kuntz I., and Cohen F., Structure-based inhibitor design by using protein models for the development of antiparasitic agents, Proc. Natl. Acad. Sci. USA, 90, (1993), 3583-3587.
13. Shoichet, B.K., Stroud, R.M., Santi, D.V. Kuntz, I.D., and Perry, K.M., Structure-based discovery of inhibitors of thymidylate synthase, Science, 259, (1993), 1445-1450.
14. Caflisch, A., Miranker, A. and Karplus, M., Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase, J. Med. Chem., 36, (1993), 2142-2167.
15. Oprea, T.I., Waller, C.L., and Marshall, G.R., Viral proteases: Structure and function, In Cellular proteolytic systems, Ciechanover, A. and Schwartz, A. (Eds.). Wiley-Liss, Inc., New York, 1994, pp. 183-221.
16. Shuker, S.B., Hajduk, P.J., Meadows R.P. and Fesik, S.W., Discovering high-affinity ligands for proteins: SAR by NMR, Science, 274, (1996), 1531-1534.
17. Lewis, R. and Dean, P., Automated site-directed drug design: the concept of spacer skeletons for primary structure generation, Proc. R. Soc. Lond. [Biol.], 236 (1989) 125-140.
18. Lewis, R. and Dean, P., Automated site-directed drug design: The formation of molecular templates in primary structure generation, Proc. R. Soc. Lond. [Biol.], 236 (1989) 141-162.
19. Ho, C.M.W. and Marshall, G.R., Cavity search: An algorithm for the isolation and display of cavity-like binding regions, J. Comput.-Aided Mol. Design, 4 (1990) 337-354.
20. Miranker, A. and Karplus, M., Functionality maps of binding sites: A multiple copy simultaneous search method, Proteins: Struct. Funct. Genet. 11 (1991) 29-34.
21. Moon, J.B., and Howe, W.J., Computer design of bioactive molecules: A method for receptor-based de novo ligand design, Proteins: Struct. Funct. Genet. 11 (1991) 314-328.
22. Nishibata, Y. and Itai, A., Automatic creation of drug candidate structures based on receptor structure: Starting point for artificial lead generation, Tetrahedron, 47 (1991) 8985-8990.
23. Böhm, H.-J., The computer program LUDI: A new method for the de novo design of enzyme inhibitors, J. Comput.-Aided Mol. Design, 6 (1992) 61-78.
24. Borman, S., New 3-D search and de novo design techniques aid drug development, C&EN, (1992) 18-26.
25. Chau, P.L., and Dean, P.M., Automated site-directed drug design: An assessment of the transferability of atomic residual charges (CNDO) for molecular fragments, J. Comput.-Aided Mol. Design, 6 (1992) 407-426.
26. Chau, P.L., and Dean, P.M., Automated site-directed drug design: Searches of the Cambridge Structural Database for bond lengths in molecular fragments to be used for automated structure assembly, J. Comput-Aided. Mol. Design, 6 (1992) 397-406.
27. Chau, P.L., and Dean, P.M., Automated site-directed drug design: The generation of a basic set of fragments to be used for automated structure assembly, J. Comput-Aided. Mol. Design, 6 (1992) 385-396.
28. Ho, C.M.W. and Marshall, G.R., FOUNDATION: A program to retrieve subsets of query elements, including active site region accessibility, from three-dimensional databases, J. Comput.-Aided Mol. Design, 7 (1993) 3-22.
29. Ho, C.M.W., and Marshall, G. R, SPLICE: A program to assemble partial query solutions from three-dimensional database searches into novel ligands, J. Comput.-Aided Mol. Design, 7 (1993) 623-647.
30. Rotstein, S.H., and Murcko, M.A., Group Build: A fragment-based method for de novo drug design, J. Med. Chem., 36, (1993) 1700-1710.
31. Ho, C.M.W. and Marshall, G.R., DBMAKER: A program to generate 3D databases based upon user specified criteria, J. Comput.-Aided Mol. Design, 8 (1994) 65-86.
32. Ho, C.M.W. and Marshall, G., De novo design of ligands. In Proceedings of the twenty-seventh annual Hawaii International Conference on system sciences, Hunter, L. (Ed.) IEEE Computer Society Press, Washington, DC, Vol. 5 1994, pp. 213-220.
33. Bohacek, R.S. and McMartin C., Multiple highly diverse structures complementary to enzyme binding sites: Results of extensive application of a de novo design method incorporating combinatorial growth, J. Am. Chem. Soc., 116 (1994) 5560-5571.
34. Roberts, N.A., Martin, J.A., Kinchington, D., Broadhurst, A.V., Craig, J.C., Duncan I. B., Galpin, S.A., Handa, B.K., Kay, J., Krohn, A., Lambert, R.W., Merrett, J.H., Mills J. S., Parkes, K.E.B., Redshaw, S., Ritchie, A.J., Taylor, D.L., Thomas, G.J., and Machin, P. J, Rational design of peptide-based HIV proteinase inhibitors, Science, 248 (1990) 358-361.
35. Tomasselli, A.G., Hui, J.O., Sawyer, T.K., Thaisrivongs, S., Hester, J.B. and Heinrikson R.L., The evaluation of non-viral substrates of the HIV protease as leads in the design of inhibitors for AIDS therapy, Adv. Exp. Med. Biol., 306 (1991) 469-482.
36. Thaisrivongs, S., Tomasselli, A., Moon, J., Hui, J., McQuade, T., Turner, S., Stronbach, J., Howe, J. Tarpley, W., and Heinrikson, R., Inhibitors of the protease from human immunodeficiency virus: Design and modeling of a compound containing a dihydroxethylene isostere insert with a high binding affinity and effective antiviral activity, J. Med. Chem., 34 (1991) 2344-2356.
37. Thanki, N., Rao, J., Foundling, S., Howe, W., Moon, J., Hui, J., Tomasselli, A., Heinrikson, R., Thaisrivongs, S., and Wlodawer, A,. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: Comparisons with molecular modeling, Protein Science, 1 (1992) 1061-1072.
38. Thaisrivongs, S., Turner, S., Strohbach, J., TenBrink, R., Tarpley, W., McQuade, T., Heinrickson., R., Tomasselli, A., Hui, J., and Howe, W., Inhibitors of the protease for the HIV: Synthesis, enzyme inhibition and antiviral activity of a series of compounds containing the dihydroxyethylene transition-state isostere, J. Med. Chem., 36 (1993) 941-952.
39. Lam, P.Y., Jadhave, P.K., Eyermann, C.J., Hodge, C.N., Ru, Y., Bacheler, L.T., Meek, J.L., Otto. M.J., Rayner, N.M., Wong, Y.N., et al., Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science, 263 (1994) 380-384.
40. Lunney, E.A., Hagen, S.E., Domagala, J.M., Humblet, C., Kosinski, J., Tait, B.D., Warmus, J.S., Wilson, M., Ferguson, D., et al., A novel nonpeptide HIV-I protease inhibitor: elucidation of the binding mode and its application in the design of related analogs, J. Med. Chem., 37 (1994) 2664-2667.
41. Thaisrivongs, S., Tomich, P.K., Watenpaugh, K.D., Chong, K.T., Howe, W.J., Yang, C.P., Strohbach, J.W., Turner, S.R., McGrath, J.P., Bohanon, M.J., et al. Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors, J. Med. Chem., 37 (1994) 3200-3204.
42. Oprea, T.I., Ho, C.M.W., and Marshall, G.R., De novo design: Ligand construction and prediction of affinity, In Application of computer-aided molecular design: Agrochemicals, materials and pharmaceuticals, Reynolds, C.H., Holloway M.K., and Cox, H., (Eds.) ACS, Washington DC, 1995, pp. 64-81.
43. Caflisch, A., Computational combinatorial ligand design: Application to human alpha-thrombin, J. Comput-Aided Mol. Design, 10 (1996) 372-396.
44. Böhm, H.-J., The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure, J. Comput.-Aided Mol. Design, 8 (1994) 243-256.
45. Wallqvist, A., Jernigan, R.L., and Covell, D.G., A preference-based free-energy parameterization of enzyme-inhibitor binding: Applications to HIV-1 protease inhibitor design, Protein Sci., 4, (1995) 1881-1903.
46. Verkhivker, G., Appelt, K., Freer, S.T., and Villafranca, J.E., Empirical free energy calculations of ligand-protein crystallographic complexes: 1. Knowledge-based ligand-protein Interaction Potentials Applied to the Prediction of HIV-1 Protease Binding Affinity, Protein Eng., 8 (1995) 677-691.
47. Head, R.D., Smythe, M.L., Oprea, T.I., Waller, C.L., Greene S.M., and Marshall, G.R., VALIDATE: A new method for the receptor-based prediction of binding affinities of novel ligands, J. Am. Chem. Soc., 118 (1996) 3959-3969.
48. Jain, A., Scoring non-covalent protein-ligand interactions: A continuous differentiable function tuned to compute binding affinities, J. Comput.-Aided Mol. Design, 10 (1996) 421-440.
49. Kollman P., free energy calculations: Application to chemical and biochemical phenomena, Chem., Rev., 93 (1993) 2395-2417.
50. Åqvist, J., Medina C. and Samuelsson, J.-E., A new method for predicting binding affinity in computer.-aided drug design. Protein Eng., 7 (1994) 385-391.
51. Åqvist, J., and Mowbray, S.L., Sugar recognition by a glucose/galactose receptor: Evaluation of binding energetics from molecular dynamics simulations, J. Biol. Chem., 270, (1995) 9978-9981.
52. Gilson, M.K., Given J.A., and Head, M.S., A new class of models for computing receptor-ligand binding affinities, Chem, Biol., 4 (1997) 87-92.
53. Head, M.S., Given J.A., and Gilson M.K., Mining minima: Direct computation of conformational free energy, J. Phys. Chem. A, 101 (1997) 1609-1618.
54. Holloway, M.K., Structure-based design of human immunodeficiency virus-I protease inhibitors: correlating calculated energy with activity in Application of computer-Aided molecular design: Agrochemicals, materials and pharmaceuticals, Reynolds, C.H., Holloway M.K., and Cox, H. (Eds.) ACS, Washington DC, 1995, p. 82.
55. Waller, C.L., Oprea, T.I., Giolitti, A., and Marshall, G.R., 3D QSAR of human immunodeficiency virus-I protease inhibitors: I. A CoMFA study employing experimentally-determined alignment rules, J. Med. Chem., 36 (1993) 4152-4160.
56. Oprea, T.I., Waller, C.L., and Marshall, G.R., 3D-QSAR of human immunodeficiency virus-I protease inhibitors: II. Predictive power using limited exploration of alternate binding modes, J. Med. Chem., 37 (1994) 2206-2215.
57. Oprea, T.I., Waller, C.L., and Marshall, G.R., 3D-QSAR of human immunodeficiency virus-I protease inhibitors: III. Interpretation of CoMFA results, Drug Des. Discov., 12 (1994) 29-51.
58. Ajay, and Murcko, M., Computational methods to predict binding free energy in ligand-receptor complexes, J. Med. Chem., 38 (1995) 4953-4967.
59. Xue, Q., and Yeung, E.S., Differences in the chemical reactivity of individual molecules of an enzyme, Nature, 373 (1995) 681-683.
60. Searle, M.S., and Williams, D.H., The cost of conformational order: Entropy changes in molecular associations, J. Am. Chem. Soc., 114 (1992) 10690-10697.
61. Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer, E.F., Brice, M.D., Rodgers, J.R., Kennard, O., Shimanouchi, T. and Tasumi M., The Protein Data Bank: A computer-based archival file for macromolecular structures, J. Mol., Biol., 112 (1977) 535-542.
62. Connolly, M., Solvent-accessible surfaces of proteins and nucleic acids, Science, 221 (1983) 709-713.
63. Bondi, A., Van der Waals volumes and radii, J. Phys. Chem., 68 (1964) 441-449.
64. Sippl, M.J., Boltzmann's principle, knowledge-based mean fields and protein folding: An approach to the computational determination of protein structures, J. Comput.-Aided Mol. Design, 7 (1993) 473-501.
65. Brooks, B.R., Bruccloleri, R.E., Olafson, D., States, D., Swaminathan, S. and Karplus, M., CHARMM: A program for macromolecular energy, minimization, and dynamics calculation, J. Comput. Chem., 4 (1983) 181-186.
66. Gilli, P., Feretti, V., Gilli G. and Borea, P.A., Enthalpy-entropy compensation in drug receptor binding, J. Phys. Chem.,98 (1994) 1515-1518.
67. octfrom structures, Chem. Rev., 5 (1993) 1281-1306.
68. Kellogg, G.E., Semus, S.F., and Abraham, D.J., HINT: A new method of empirical hydrophobic field calculation for CoMFA, J. Comput.-Aided Mol., Design, 5 (1991) 545-552.
69. Le Grand, S.M. and Merz, K.M., Rapid approximation to molecular surface area via the use of Boolean logic and look-up tables, J. Comput. Chem., 14 (1993) 349-352.
70. Still, W.C., Tempczyk, A., Hawley R.C., and Hendrickson, T., Semianalytical treatment of solvation for molecular mechanics and dynamics, J. Am. Chem. Soc., 112 (1990) 6127.
71. Oprea, T.I., Head, R.D., and Marshall, G.R., The basis of cross-reactivity for a series of steroids binding to a monoclonal antibody against progesterone (DB3): A molecular modeling and QSAR study, In QSAR and molecular modelling: Concepts, computational tools and biological applications, Sanz, F., Giraldo, J., and Manaut, F. (Eds.) Prous Science Publishers, Barcelona, 1995, pp. 451-455.
72. Rose, P.W., Scoring methods in ligand design, 2nd USCF Course in Computer-Aided Molecular Design, San Francisco, CA, 1997.
73. Gilson, M.K., Given, J.A., Bush, B.L., and McCammon, J.A., The statistical-thermodynamic basis for computation of binding affinities: A critical review, Biophys. J., 72 (1997) 1047-1069.
74. García, A.E., and Stiller, L. Computation of the mean residence time of water in the hydration shells of biomolecules, J. Comput. Chem. 14 (1993) 1396-1406.
75. Hummer, G., Garcia, A.E., and Soumpasis, D.M., Hydration of nucleic acid fragments: Comparison of theory and experiment for high-resolution crystal structures of RNA, DNA, and DNA-drug complexes, Biophys. J., 68 (1995) 1639-1652.
76. Oprea, T.I., and Waller, C.L., Theoretical and practical aspects of three dimensional quantitative structure-activity relationships. In Reviews in Computational Chemistry, vol. 11, Lipkowitz, K.B., and Boyd, D.B. (Eds), Wiley, New York, 1997, pp. 127-182.